Cadrenal Therapeutics, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold CVKD, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
3
Funds holding
$29323
Total value held
Flat
1 added/new · 1 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $28140 | 5496 | +1974 | +56.05% |
| 2 | Wells Fargo & Company/Mn | $671 | 99 | — | Held |
| 3 | Morgan Stanley | $512 | 100 | -980 | -90.74% |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.